# Masimo Corporation (MASI)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $9.75B  
**Price:** $179.95

> Masimo Corporation is a global medical technology company that develops, manufactures, and markets innovative noninvasive patient monitoring technologies, sensors, patient monitors, and automation and connectivity solutions. Its healthcare segment, the primary revenue driver, focuses on hospital automation platforms like Masimo Hospital Automation™ and Masimo SafetyNet®, alongside remote patient monitoring, telehealth, and telemonitoring devices to enhance care delivery in hospitals and beyond. Notable technologies include Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which excels in challenging conditions and is widely used in top hospitals. The company also offers consumer health products. Previously encompassing a non-healthcare segment for premium audio products, Masimo Corporation has divested that business to concentrate on medical innovations. Founded in 1987 and headquartered in Irvine, California, it plays a vital role in advancing patient safety and clinical efficiency across healthcare settings worldwide.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $1.53B | $945M | $310M | -$152M | — |
| 2024 | $1.40B | $794M | $63M | -$305M | — |
| 2023 | $1.28B | $766M | $166M | $82M | — |
| 2022 | $2.04B | $1.06B | $210M | $144M | — |
| 2022 | $1.24B | $808M | $276M | $230M | — |
| 2021 | $1.14B | $743M | $256M | $240M | — |
| 2019 | $938M | $629M | $221M | $196M | — |
| 2018 | $858M | $575M | $208M | $194M | — |
| 2017 | $790M | $522M | $184M | $125M | — |
| 2016 | $713M | $478M | $436M | $311M | — |
| 2016 | $630M | $410M | $120M | $83M | — |
| 2015 | $587M | $391M | $104M | $73M | — |
| 2013 | $547M | $359M | $80M | $58M | — |
| 2012 | $493M | $326M | $85M | $62M | — |
| 2011 | $439M | $294M | $87M | $64M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2026 | $1.70B | $978M | $721M | $152M | $524M |
| 2024 | $2.63B | $1.57B | $1.05B | $124M | $765M |
| 2023 | $3.04B | $1.68B | $1.36B | $163M | $906M |
| 2022 | $3.21B | $1.87B | $1.34B | $203M | $957M |
| 2022 | $1.89B | $337M | $1.55B | $745M | — |
| 2021 | $1.71B | $305M | $1.41B | $641M | — |
| 2019 | $1.40B | $228M | $1.17B | $568M | — |
| 2018 | $1.15B | $186M | $969M | $552M | — |
| 2017 | $905M | $181M | $724M | $315M | — |
| 2016 | $821M | $260M | $560M | $306M | — |
| 2016 | $602M | $326M | $275M | $132M | — |
| 2015 | $565M | $257M | $306M | $134M | — |
| 2013 | $439M | $112M | $326M | $95M | — |
| 2012 | $375M | $99M | $273M | $72M | — |
| 2011 | $366M | $86M | $277M | $130M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | $218M | $19M | $198M |
| 2024 | $196M | $21M | $175M |
| 2023 | $94M | $38M | $56M |
| 2022 | $29M | $53M | -$23M |
| 2022 | $265M | $26M | $239M |
| 2021 | $211M | $73M | $139M |
| 2019 | $222M | $68M | $153M |
| 2018 | $240M | $17M | $222M |
| 2017 | $56M | $44M | $12M |
| 2016 | $419M | $20M | $399M |
| 2016 | $117M | $50M | $67M |
| 2015 | $96M | $75M | $21M |
| 2013 | $55M | $9M | $46M |
| 2012 | $75M | $11M | $65M |
| 2011 | $79M | $5M | $74M |

Source: [CompaniesByCap](https://companiesbycap.com/company/MASI)